Table 1. Demographic characteristics, clinical data and subtypes.
| Subtype A | Subtype B | Subtype C | Total | ||
|---|---|---|---|---|---|
| N | 232 | 770 | 425 | 1427 | |
| Gender 1 | Male (%) | 147 (63.4% | 727 (94.7%) | 184 (43.3%) | 1058 (74%) |
| Female (%) | 85 (36.6%) | 41 (5.3%) | 241 (56.7%) | 367 (2%) | |
| Age (years) | Median | 33.6 | 34.4 | 36.4 | 34.6 |
| St. Deviation | 9.8 | 9.8 | 15.3 | 11.8 | |
| Range | [3–63] | [0–78] | [0–85] | [0–85] | |
| Risk | Hetero (%) | 51 (22%) | 48 (6.2%) | 376 (88.4%) | 475 (33%) |
| IVDU (%) | 123 (53%) | 36 (4.7%) | 10 (2.4%) | 169 (12%) | |
| MSM (%) | 29 (12.5%) | 638 (82.9%) | 10 (2.4%) | 677 (48%) | |
| Other (%) | 29 (12.5%) | 48 (6.2%) | 29 (6.8%) | 106 (7%) | |
| Country of Birth | Ethiopia (%) | 3 (1.3%) | 2 (0.3%) | 377 (88.9%) | 383 (27%) |
| FSU (%) | 165 (71.1%) | 100 (13%) | 10 (2.4%) | 275 (19%) | |
| Israel (%) | 41 (17.6%) | 564 (73.2%) | 24 (5.4%) | 628 (44%) | |
| Other /unknown (%) | 23 (9.9%) | 104 (13.5%) | 14 (3.3%) | 141 (10%) | |
| CD4 (cells/μl) | Median | 355 | 386 | 248 | 336 |
| St. Deviation | 241 | 264 | 305 | 280 | |
| 25% quartile | 160 | 266 | 126 | 196 | |
| 75% quartile | 500 | 546 | 382 | 498 | |
| Range | [4–1950] | [4–1558] | [5–3429] | [4–3429] | |
| HIV RNA log 10 (copies/ml) | Median | 4.48 | 4.67 | 4.7 | 4.66 |
| Std. Deviation | 5.73 | 6.51 | 6.2 | 6.41 | |
| Range | [2.00–6.79] | [2.60–7.90] | [2.45–7.29] | [2.00–7.90] | |
| Seroconverters (%) | 4 (1.7%) | 37 (4.8%) | 19 (4.5%) | 60 (4.2%) |
Subtype-B patients had significantly higher CD4 counts than the other groups (p<0.0001) suggesting early presentation.
1for two B-subtype patients gender was not reported